Laura G. Leahy, Dr.N.P., A.P.R.N., F.A.A.N.P.
Board Certified Psychiatric & Addictions Advanced Practice Nurse
Master Clinician in Psychopharmacology
Fellow in the American Association of Nurse Practitioners
Paolo Mannelli, M.D.
Department of Psychiatry and Behavioral Sciences
Associate Medical Director
Division of Addiction
Duke Addictions Program
Brian W. O’Connor, M.D.
Middlesex Recovery, P.C.
Consultants are paid by Alkermes.
Genie L. Bailey, M.D., is a consultant or on advisory boards for Alkermes, Inc., Braeburn Pharmaceuticals, and BioDelivery Sciences International, Inc. (BDSI). She is on the speaker bureau for Alkermes, Indivior PLC, and BDSI. She has received non-financial support from Indivior (medication for study and travel costs) and Alkermes (travel costs). Her institution has received grant support from Braeburn Pharmaceuticals and Indivior.
Laura P. Bamford, M.D., M.S.C.E., is a consultant for Alkermes, Inc., and is on the speaker bureau. She has received research support from Janssen Pharmaceuticals, Inc.
Jeffrey A. Berman, M.D., D.F.A.S.A.M., is a consultant for Alkermes, Inc. He serves or has served on the speaker bureaus for Alkermes, Sunovion Pharmaceuticals Inc., and Otsuka Pharmaceutical Co., Ltd.
Tim Fong, M.D., is a consultant for Alkermes, Inc., and for Onward Method, Inc. He is on the speaker bureau for Indivior PLC. Dr Fong has received research support from Constellation Behavioral Health.
Linda J. Frazier, M.A., R.N., M.C.H.E.S., is a NIATx consultant for materials development and training. She is also a consultant for Alkermes, Inc.
Thomas R. Kosten, M.D., is a consultant for Alkermes, Inc.; Neurocrine Biosciences, Inc.; Novartis Pharmaceuticals Corporation; and Purdue Pharma L.P. He receives research support from Alkermes.
Laura G. Leahy, Dr.N.P., A.P.R.N., F.A.A.N.P., is a consultant for Alkermes, Inc. and the Shire Nurse Advisory Board. She is on the speaker bureau for Alkermes, Genomind, and NEOS Therapeutics, Inc. She has also been an author/editor for American Psychiatric Association Publishing (Manual of Clinical Psychopharmacology for Nurses, 2013).
Paolo Mannelli, M.D., is a consultant for Alkermes, Inc., and Guidepoint Global. He has received research support from Alkermes and Orexo AB (publ).
Brian W. O’Connor, M.D., is a consultant for Alkermes, Inc. He is also on the speaker bureau for Alkermes.
See Important Safety Information for VIVITROL below. See Prescribing Information and Medication Guide. Review Medication Guide with your patients.